The ROE as of September 2024 (TTM) for Eupraxia Pharmaceuticals Inc. (EPRXF) is -198.59%

According to Eupraxia Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -198.59%. This represents a change of 121.95% compared to the average of -89.48% of the last 4 quarters.

Eupraxia Pharmaceuticals Inc. (EPRXF) Historical ROE (quarterly & annually)

How has EPRXF ROE performed in the past?

The mean historical ROE of Eupraxia Pharmaceuticals Inc. over the last ten years is -212.90%. The current -198.59% ROE has changed -6.72% with respect to the historical average. Over the past ten years (40 quarters), EPRXF's ROE was at its highest in in the September 2020 quarter at 4.96%. The ROE was at its lowest in in the December 2023 quarter at -184.83%.

Eupraxia Pharmaceuticals Inc. (EPRXF) ROE by Quarter and Year

Discovering the peaks and valleys of Eupraxia Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Eupraxia Pharmaceuticals Inc. (EPRXF) Average ROE

How has EPRXF ROE performed in the past?

The current ROE of Eupraxia Pharmaceuticals Inc. (EPRXF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Eupraxia Pharmaceuticals Inc. (EPRXF) ROE vs. Peers

How is EPRXF’s ROE compared to its peers?

Eupraxia Pharmaceuticals Inc.’s ROE is less than Adynxx, Inc. (0%), less than Ascletis Pharma Inc. (0%), less than AVAX Technologies, Inc. (-0.82%), greater than Eliem Therapeutics, Inc. (-344.15%), greater than Inhibrx, Inc. (-47.03%), less than Merrimack Pharmaceuticals, Inc. (1.62%), greater than Celcuity Inc. (-35.28%), greater than Enliven Therapeutics, Inc. (-60.83%), greater than Transgene SA (-29.31%), greater than Champions Oncology, Inc. (-178.29%), less than MAIA Biotechnology, Inc. (323.52%), greater than Lumos Pharma, Inc. (-18051.81%), greater than Processa Pharmaceuticals, Inc. (-157.99%), greater than Alpha Cognition Inc. (-151.10%), less than Acurx Pharmaceuticals, Inc. (537.50%), greater than Fennec Pharmaceuticals Inc. (-371.20%), greater than null (-52.10%),

Build a custom stock screener for Eupraxia Pharmaceuticals Inc. (EPRXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eupraxia Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eupraxia Pharmaceuticals Inc. (EPRXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eupraxia Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.